Skip to main content
Premium Trial:

Request an Annual Quote

Novartis to Use Beyond Genomics Systems Biology Platform for Cardiovascular Biomarker Study

NEW YORK, Feb. 11-Novartis will use Beyond Genomics' systems biology platform to analyze cardiovascular disease patient samples and identify diagnostic and prognostic markers for the disease, Beyond Genomics said today.

 

Under the agreement, Novartis will provide plasma samples and research funding. Beyond Genomics will compare normal and cardiovascular disease-related samples in order to characterize molecular markers.

 

Beyond Genomics, based in Waltham, Mass., combines proteomic and metabolomic analysis with pattern recognition and data mining software for a systems approach to drug discovery and development.

 

 

 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.